Health Care & Life Sciences » Biotechnology | Tiziana Life Sciences PLC

Tiziana Life Sciences PLC | Balance Sheet

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
76.00
2,266.00
8,903.00
4,703.00
48.00
4,165
Total Accounts Receivable
-
103.00
273.00
93.00
1,520.00
1,015
Other Current Assets
-
91.00
74.00
227.00
245.00
250
Total Current Assets
-
2,460.00
9,250.00
5,023.00
1,813.00
5,430
Net Property, Plant & Equipment
-
-
-
28.00
18.00
6
Total Assets
126.00
2,460.00
9,250.00
5,051.00
1,831.00
5,436
ST Debt & Current Portion LT Debt
230.00
206.00
216.00
225.00
234.00
Other Current Liabilities
-
477.00
530.00
1,512.00
3,280.00
Total Current Liabilities
-
683.00
746.00
1,737.00
3,514.00
Long-Term Debt
-
2,259.00
12,287.00
13,535.00
-
Other Liabilities
272.00
-
-
-
-
Total Liabilities
272.00
2,942.00
13,033.00
15,272.00
3,514.00
Common Equity (Total)
6,749.00
482.00
3,783.00
10,221.00
1,683.00
Total Shareholders' Equity
146.00
482.00
3,783.00
10,221.00
1,683.00
Total Equity
146.00
482.00
3,783.00
10,221.00
1,683.00
Liabilities & Shareholders' Equity
126.00
2,460.00
9,250.00
5,051.00
1,831.00
Preferred Stock (Carrying Value)
6,603.00
-
-
-
-

About Tiziana Life Sciences

View Profile
Address
55 Park Lane
London Greater London W1K 1NA
United Kingdom
Employees -
Website http://www.tizianalifesciences.com
Updated 07/08/2019
Tiziana Life Sciences Plc operates as a clinical stage biotechnology company that focuses on the discovery and development of drugs that treat human disease in oncology and immunology. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom. .